Figure 2From: EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry Principal design of EARLY. Patients will be recruited on a consecutive basis, given their compliance with the in- and exclusion criteria defined, in a ratio of 7 (AZM) to 3 (ACE inhibitors).Back to article page